Research in the United States has shown that obese people are less likely than their normal-weight peers to undergo screening for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell and Scott Klarenbach, from the University of Alberta's Faculty of Medicine & Dentistry, have undertaken a study to see if this trend is also true in Canada.
"As obesity is associated with higher rates of some types of cancer, it's important to determine if the presence of obesity influences the use of screening tests," said Padwal.
In 2007 almost 38,000 women participated in a national survey. The women, aged 20-69, were asked questions including:
-- their Body Mass Index (to determine the level of obesity)
-- whether they have a regular doctor
-- did they get breast, colon and cervical cancer screening tests regularly; if so, how often; if not, what are the reasons?
Padwal said for the most part, the results were encouraging. For breast and colon cancer screening the data showed no difference between overweight/obese women and normal-weight women.
But for cervical cancer screening the results were different. While 82 per cent of women said they had a pap smear in the past three years, testing decreased as BMI levels increased. "Obese women are 30 to 40 per cent less likely—depending on the degree of obesity—to have recommended cervical cancer screening performed."
Padwal says the results also showed obese women are two times more likely than normal-weight women to state that fear—including fear of pain, embarrassment or of finding something wrong—was the reason they did not have a pap smear.
"I am reassured that for mammograms and colorectal cancer screening, the presence of obesity doesn't impact their use, which is different from reports in other countries. However, the gap with pap smears is concerning," he said.
Padwal believes this is an issue that needs to be addressed through increased awareness and vigilance on the part of patients and health care providers. He says more studies are needed to determine if other barriers exist and, if so, what are the best methods of removing those barriers.
Source: University of Alberta
Related stories:
Link between nationality and cervical cancer
Gynaecological screening tests for cervical cancer have been available to all women in Sweden for almost four decades. Despite this, many immigrant women have a higher risk of developing the disease than Swedish-born women, according to a new study from the medical university Karolinska Institutet.
Study confirms colorectal cancer screening should start at age 50
Colorectal adenomas, the precursor polyps in virtually all colorectal cancers, occur infrequently in younger adults, but the rate sharply increases after age 50. Additionally, African Americans have a higher rate of proximal, or right-sided, polyps, and may have a worse prognosis for survival if the polyps become cancerous. Therefore, the results of this study further emphasize the importance of colonoscopies, which view the entire colon, for the prevention of colorectal cancer beginning at age 50.
Cervical cancer prevention should focus on vaccinating adolescent girls
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies, according to an analysis by Harvard School of Public Health (HSPH) researchers in the August 21, 2008 issue of
The New England Journal of Medicine.
Low vitamin D levels pose large threat to health
Researchers at Johns Hopkins are reporting what is believed to be the most conclusive evidence to date that inadequate levels of vitamin D, obtained from milk, fortified cereals and exposure to sunlight, lead to substantially increased risk of death.
2 different breast cancer screening strategies are equally effective
An organized population-based breast cancer screening program in Norway and an approach to screening that relies on physician- and self-referrals in Vermont are equally sensitive for detecting cancer, researchers report in the July 29 online issue of the
Journal of the National Cancer Institute. But the recall rate for abnormal mammograms was lower in Norway.
No need for gene screens in breast cancer families
Research reported today should provide relief to women who are worried after a relative's breast cancer diagnosis. The study in the open access journal
BMC Cancer shows that a family history of breast cancer does not give a useful indication of the likelihood that a woman will develop it herself at an early age.
Over-the-counter anesthetic gel puts the squeeze on mammogram pain
The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of
Radiology.
Study on government's controversial choice of HPV vaccine
The UK government may save up to £18.6 million a year by deciding to use the HPV vaccine Cervarix, given that it is equally effective as the more expensive Gardasil in preventing cervical abnormalities, according to a study published on BMJ.com today.